Morphofunctional Alterations in Endocrine Pancreas of Short- and Long-term Dexamethasone-treated Rats

Abstract

Long-term dexamethasone therapy may induce peripheral insulin resistance (IR), which in turn elicits increased beta-cell function and proliferation. However, whether such adaptive compensations occur during short-term treatment with dexamethasone is unclear. Here, we compared morphofunctional parameters in endocrine pancreas after short- and long-term dexamethasone administration. Groups of rats received daily i. p. injection of 1 mg/kg b. w. dexamethasone for 1 (DEX-1), 3 (DEX-3), or 5 consecutive days (DEX-5), whilst control rats were saline-treated (CTL). Despite the absence of apparent IR in DEX-1 rats, this group exhibited increased circulating insulin levels and glucose-stimulated insulin secretion (GSIS), compared to the CTL group (p<0.05). Evident IR as well as marked hyperinsulinemia and GSIS, as judged by the static and dynamic insulin secretion values, were observed in DEX-3 and DEX-5 rats (p<0.05). GSIS in islets cultured with 1 μM dexamethasone was lower compared to the control (p<0.05). Marked increases in beta-cell proliferation were observed in DEX-3 and DEX-5 rats, compared to CTL and DEX-1 rats (p<0.05). The alterations observed in DEX-3 rats were more pronounced in DEX-5 rats, which also exhibited a higher content of islet Cdk4 and Cd2 proteins, compared to the CTL group (p<0.05). We conclude that short-term dexamethasone treatment (DEX-1) induces an increase in beta-cell function that does not require the presence of discernible IR. As the treatment continues, the IR develops rapidly, and increased insulin secretion as well as beta-cell hyperplasia is demanded for the appropriate maintenance of glucose homeostasis.

Key words

beta-cell proliferation - dexamethasone - glucocorticoid - insulin secretion - insulin resistance - short- and long-term treatment

References

• 1 Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids.  Pharmacol Ther. 2002;  96 23-43
• 2 Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets.  Clin Sci. 1999;  96 513-523
• 3 Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.  Diabetes. 1993;  42 1663-1672
• 4 Karlsson S, Ostlund B, Myrsén-Axcrona U, Sundler F, Ahrén B. Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness.  Pancreas. 2001;  22 148-156
• 5 Nicod N, Giusti V, Besse C, Tappy L. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers.  Obes Res. 2003;  11 625-631
• 6 Rafacho A, Cestari TM, Taboga SR, Boschero AC, Bosqueiro JR. High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets.  Am J Physiol Endocrinol Metab. 2009;  296 E681-E689
• 7 Rafacho A, Marroquí L, Taboga SR, Abrantes JL, Silveira LR, Boschero AC, Carneiro EM, Bosqueiro JR, Nadal A, Quesada I. Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets.  Endocrinology. 2010;  151 85-95
• 8 Rafacho A, Giozzet VA, Boschero AC, Bosqueiro JR. Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance.  Pancreas. 2008;  36 284-293
• 9 Rafacho A, Roma LP, Taboga SR, Boschero AC, Bosqueiro JR. Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat islets.  Can J Physiol Pharmacol. 2007;  85 536-545
• 10 Beith JL, Alejandro EU, Johnson JD. Insulin stimulates primary beta-cell proliferation via Raf -1 kinase.  Endocrinology. 2008;  149 2251-2260
• 11 Rafacho A, Ribeiro DL, Boschero AC, Taboga SR, Bosqueiro JR. Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats.  Int J Exp Pathol. 2008;  89 264-275
• 12 Kawai A, Kuzuya N. On the role of glucocorticoid in glucose-induced insulin secretion.  Horm Metab Res. 1977;  9 361-365
• 13 Burén J, Lai YC, Lundgren M, Eriksson JW, Jensen J. Insulin action and signalling in fat and muscle from dexamethasone-treated rats.  Arch Biochem Biophys. 2008;  474 91-101
• 14 Mokuda O, Sakamoto Y, Ikeda T, Mashiba H. Sensitivity and responsiveness of glucose output to insulin in isolated perfused liver from dexamethasone-treated rats.  Horm Metab Res. 1991;  23 53-55
• 15 Beard JC, Halter JB, Best JD, Pfeifer MA, Porte Jr D. Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men.  Am J Physiol. 1984;  247 E592-E596
• 16 Novelli M, De Tata V, Bombara M, Lorenzini A, Masini M, Pollera M, Bergamini E, Masiello P. Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats.  J Endocrinol. 1999;  162 425-432
• 17 Sood A, Ismail-Beigi F. Effect of dexamethasone on insulin secretion: Examination of some underlying mechanisms.  Endocr Pract. 2010;  29 1-24
• 18 Qi D, Pulinilkunnil T, An D, Ghosh S, Abrahani A, Pospisilik JA, Brownsey R, Wambolt R, Allard M, Rodrigues B. Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism.  Diabetes. 2004;  53 1790-1797
• 19 Zakrzewska KE, Cusin I, Stricker-Kongrad A, Boss O, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F. Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat.  Diabetes. 1999;  48 365-370
• 20 Angelini N, Rafacho A, Boschero AC, Bosqueiro JR. Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats.  Diabetes Res Clin Pract. 2010;  87 184-191
• 21 Ahrén B. Evidences that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans.  Diabetologia. 2008;  51 1018-1024
• 22 Rafacho A, Quallio S, Ribeiro DL, Taboga SR, Paula FM, Boschero AC, Bosqueiro JR. The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment.  Acta Physiol. 2010;  200 223-235
• 23 Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A. Beta-cell adaptation and decompensation during the progression of diabetes.  Diabetes. 2001;  50 (Suppl 1) S154-S159

Correspondence